Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001615774-17-000856

Options or other derivatives

  • Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SULLIVAN GREGORY M Chief Medical Officer 2017-03-01 Grant or award · Stock Option +75,000 75,000 D: show line 1 in the form
SULLIVAN GREGORY M Chief Medical Officer 2017-03-01 Grant or award · Stock Option +75,000 75,000 D: show line 2 in the form
Loading xslF345X03/s105457_form4.xml…